| DIRECT COMPETITOR COMPARISON | |
| NAII | GORX | INBP.OB | PRGO | Industry | | Market Cap: | 54.71M | 8.42M | 3.85M | 3.60B | 93.59M | | Employees: | 181 | 271 | 115 | 7,250 | 280 | | Qtrly Rev Growth (yoy): | -13.10% | -33.10% | 17.90% | 15.90% | 9.60% | | Revenue (ttm): | 71.35M | 19.05M | 41.04M | 2.08B | 71.35M | | Gross Margin (ttm): | 14.50% | 13.86% | 25.72% | 30.24% | 50.77% | | EBITDA (ttm): | 5.74M | -11.31M | -2.47M | 365.56M | 220.78K | | Oper Margins (ttm): | 3.62% | -75.79% | -7.18% | 14.16% | 7.24% | | Net Income (ttm): | 1.38M | -11.86M | -12.06M | 163.82M | N/A | | EPS (ttm): | -0.190 | -1.547 | -0.791 | 1.793 | N/A | | P/E (ttm): | N/A | N/A | N/A | 21.97 | 16.68 | | PEG (5 yr expected): | N/A | N/A | N/A | 1.19 | 0.96 | | P/S (ttm): | 0.76 | 0.44 | 0.09 | 1.73 | 1.19 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.72 | 0.30% | 57.41B | 12.37 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.97 | 1.25% | 13.87B | 16.05 | | Genzyme Corp. | GENZ | 49.87 | -0.80% | 13.23B | 28.43 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.54 | 0.61% | 41.88B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.45 | 0.40% | 9.00B | 1029.59 | | Teva Pharmaceutical Industries Limited | TEVA | 53.99 | 0.78% | 47.57B | 49.40 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.67 | 1.02% | 4.00B | 19.42 | | King Pharmaceuticals Inc. | KG | 11.73 | 0.51% | 2.91B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.91 | -1.59% | 5.47B | 109.88 | | Pfizer Inc. | PFE | 18.58 | -0.32% | 149.93B | 15.43 | | Johnson & Johnson | JNJ | 64.36 | 0.31% | 177.58B | 14.06 | | GlaxoSmithKline plc | GSK | 42.77 | 0.78% | 108.42B | 13.45 | | Sanofi-Aventis | SNY | 39.37 | -0.38% | 102.80B | N/A | | Novartis AG | NVS | 55.51 | -0.48% | 126.07B | 16.62 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.35 | -1.19% | N/A | N/A | | AstraZeneca plc | AZN | 46.43 | 1.78% | 67.32B | 9.32 | | Abbott Laboratories | ABT | 53.70 | -1.00% | 83.06B | 14.55 | | Bristol-Myers Squibb Co. | BMY | 25.18 | 0.08% | 49.88B | 13.03 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | GORX | | GeoPharma Receives Guidance From NASDAQ Regarding Minimum Stockholders' Equity Requirement
Thu 8:30am -
GlobeNewswire | | • | PRGO | | Israel Stocks: Israel stocks gain as drug makers advance
Wed, Dec 2 -
at MarketWatch | | • | PRGO | | Coverage initiated on Perrigo by RBC Capital Mkts
Tue, Dec 1 -
Briefing.com | | • | PRGO | | Israel Stocks: Israel stocks off; Osem up, Migdal off on reports
Sun, Nov 29 -
at MarketWatch | | • | GORX | | GEOPHARMA, INC. Financials
Sat, Nov 28 -
EDGAR Online Financials | | • | GORX | | GEOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Wed, Nov 25 -
EDGAR Online | | • | PRGO | | A Relative Price Strength Screen for All Markets
Wed, Nov 25 -
Zacks.com | | • | GORX | | GEOPHARMA, INC. Files SEC form 10-Q/A, Quarterly Report
Tue, Nov 24 -
EDGAR Online | | • | GORX | | Weak demand hurts GeoPharma sales, profit
Tue, Nov 24 -
at bizjournals.com | | • | PRGO | | Israel Stocks: Israel stocks steady; BarCap sees no rate change
Sun, Nov 22 -
at MarketWatch | | • | PRGO | | Flu season, ailing economy aiding Mich. drug maker
Fri, Nov 20 -
AP | | • | INBP.OB | | INTEGRATED BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
Thu, Nov 19 -
EDGAR Online | | • | INBP.OB | | INTEGRATED BIOPHARMA INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and
Mon, Nov 2 -
EDGAR Online | | • | INBP.OB | | INTEGRATED BIOPHARMA INC Financials
Fri, Oct 16 -
EDGAR Online Financials | | • | INBP.OB | | INTEGRATED BIOPHARMA INC Files SEC form 10-K, Annual Report
Tue, Oct 13 -
EDGAR Online | | • | INBP.OB | | INTEGRATED BIOPHARMA INC Financials
Wed, Jun 17 -
EDGAR Online Financials | | | All Headlines for these symbols... |
|
|
|
0.10% Nasdaq 
Competitors
